Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review

Amir Aziz; Szymon Musiol; William E. Moody; Luke Pickup; Robert Cooper; Professor Gregory Lip

doi:10.1111/eci.13593

Abstract

1 min read

Using clinical predictors to decide whom to test is a feasible alternative to investigating all comers. Nonetheless, currently there is not enough evidence to unequivocally recommend for or against this strategy. Further validation of current predictors and identification of new ones remain open research avenues.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Dietary intervention with edible medicinal plants and derived products for prevention of Alzheimer's disease: A compendium of time-tested strategy

Yu Peng, Hongxun Tao, Shengpeng Wang, Jianbo Xiao, Yitao Wang, Huanxing Su

Article2020

The Photosensitizing Efficacy of Micelles Containing a Porphyrinic Photosensitizer and KI against Resistant Melanoma Cells

Kelly A. D. F. Castro, Letícia D. Costa, Juliana A. Prandini, Juliana C. Biazzotto, Augusto C. Tomé, Michael R Hamblin, Maria G. P. M. S. Neves, M. Amparo F. Faustino, Roberto Santana da Silva

Article2018

Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association

Rachel K. Johnson, Alice H. Lichtenstein, Cheryl A.M. Anderson, Jo Ann S. Carson, Jean‐Pierre Després, Frank B Hu, Penny M. Kris‐Etherton, Jennifer J. Otten, Amytis Towfighi, Judith Wylie‐Rosett

Article2016

Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review

Benjamin A. Goldstein, Ann Marie Návar, Michael Pencina, John P A Ioannidis

Article2012

Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature

Joel Gagnier, David Moher, Heather Boon, Joseph Beyene, Claire Bombardier